TABLE 2.
Epidemiologic cutoff values of amphotericin B, itraconazole, posaconazole, and voriconazole for two clinically relevant Fusarium species complexes and F. verticillioides as determined by the CLSI broth microdilution methoda
Species or species complex | Antifungal agentb | MIC (μg/ml) |
Calculated statistical ECV (μg/ml)c |
|||
---|---|---|---|---|---|---|
Range | Moded | ≥95% | ≥97.5% | ≥99% | ||
F. verticillioides | AMB | 0.5–16 | 2 | 4 | 4 | 4 |
ITR | 1–≥16 | 16 | ND | ND | ND | |
POS | ≤0.25–≥16 | 0.5 | 2 | 2 | 2 | |
VOR | 0.5–≥16 | 2 | 4 | 4 | 8 | |
F. oxysporum SC | AMB | ≤0.25–16 | 2 | 4 | 8 | 8 |
ITR | 1–≥16 | 16 | 32 | 32 | 32 | |
POS | 0.5–16 | 2 | 8 | 8 | 8 | |
VOR | 0.5–≥16 | 4 | 8 | 16 | 16 | |
F. solani SC | AMB | ≤0.25–16 | 2 | 4 | 8 | 8 |
ITR | 0.5–≥16 | 16 | 16 | 32 | 32 | |
POS | 1–≥16 | 8 | 32 | 32 | 32 | |
VOR | 0.5–≥16 | 8 | 16 | 32 | 32 |
ECVs were defined for pooled distributions for ≥100 isolates from ≥3 laboratories using the methodology of CLSI document M38-A2 (25, 35).
AMB, amphotericin B; ITR, itraconazole; POS, posaconazole; VOR, voriconazole.
Calculated ECVs comprising ≥95%, ≥97.5%, and ≥99% of the statistically modeled population. ND, not determined (due to insufficient data).
MIC most frequently obtained for each distribution.